arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

INCYTE CORP

INCY
$117.98 ▼ -4.94 (-4.02%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
69 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
86
Health
Excellent
Bullish
auto_awesome

Analytical Summary

INCYTE CORP shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $24.0B
Dividend Yield —
Revenue Growth 14.0% ↘
Op. Margin -45.5% ↘
ROIC -14.3% ↘
FCF / Share $-3.32 ↘
Trailing P/E —
Price / Book 4.3x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

69-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.56B
↑ +14.0% —
Net Income Profit after all expenses
$303.33M
↑ +91.7% —
Operating Margin Operating profit as % of sales
-45.5%
↓ -209.1% 86th
FCF / Share Free cash flow per share
$-3.32
↓ -231.1% —
Long-Term Debt Long-term obligations
$420.00M
↑ +43.1% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
88
Returns →
90
Cash Quality ↑
69

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 18 years · 69 quarters